XML 60 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended 12 Months Ended
Dec. 31, 2012
Dec. 31, 2013
Mar. 31, 2012
Dec. 31, 2013
Series A Convertible Preferred Stock
Mar. 31, 2012
Series A Convertible Preferred Stock
Dec. 31, 2013
Warrant Common
Dec. 31, 2013
Common stock warrants
Mar. 31, 2012
Common stock warrants
Cash flows from Operating Activities:                
Net income (loss) $ (4,238) $ 7,308 $ (11,944)          
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                
(Benefit) provision for loan losses (42)   368          
Fair value adjustments of Loans, Notes and Certificates, net 595 33 1          
Change in loan servicing liability carried at fair value   936            
Change in loan servicing asset carried at fair value   (534)            
Stock-based compensation and warrant expense 1,110 6,490 660          
Depreciation and amortization 236 1,663 150          
Gain on sales of Loans at fair value (329) (3,862)            
Other, net (118)   (43)          
Loss on disposal of property, equipment and software   30            
Purchase of Whole Loans sold at fair value (9,290) (442,362)            
Proceeds from sales of Whole Loans at fair value 9,619 446,224            
Net change in:                
Accrued interest receivable (3,170) (10,454) (2,351)          
Other assets (649) (21,021) (1,468)          
Due from related parties (75) (240) (40)          
Accounts payable 330 1,788 620          
Accrued interest payable 4,070 11,063 2,604          
Accrued expenses and other liabilities 1,558 4,077 357          
Net cash provided by (used in) operating activities (393) 1,139 (11,086)          
Cash flows from Investing Activities:                
Purchase of Loans at fair value (598,622) (1,618,404) (320,014)          
Purchase of Loans at amortized cost     (1,064)          
Principal payments of Loans at fair value 160,787 511,232 105,306          
Principal payments of Loans at amortized cost 345   1,349          
Proceeds from recoveries and sales of charged-off Loans at fair value 247 1,716            
Proceeds from recoveries and sales of charged-off Loans at amortized cost 22              
Net change in restricted cash (2,622) (4,724) (4,000)          
Purchase of property, equipment and software (1,302) (10,435) (383)          
Net cash used in investing activities (441,145) (1,120,615) (218,806)          
Cash flows from Financing Activities:                
Payable to Investors 1,517 1,868 533          
Proceeds from issuance of Notes and Certificates 606,862 1,618,269 319,704          
Payments on Notes and Certificates (163,946) (504,330) (101,950)          
Payments on charged-off Notes and Certificates from recoveries/sales of related charged off Loans at fair value (219) (1,669)            
Payments on loans payable (370)   (2,601)          
Proceeds from exercise of warrants       221 10 150    
Repurchase of common stock (12)              
Proceeds from stock options exercised 864 1,715 158          
Net cash provided by financing activities 462,845 1,116,224 247,800          
Net (Decrease) increase in cash and cash equivalents 21,307 (3,252) 17,908          
Cash and cash equivalents, beginning of period 31,244 52,551 13,336          
Cash and cash equivalents, end of period 52,551 49,299 31,244          
Supplemental disclosure of cash flow information:                
Cash paid for interest 52,511 176,195 28,063          
Non-cash exercise of stock warrants             137 2,345
Reclassification of Loans at amortized cost to Loans held at fair value 2,109              
Non-cash investing activity-accrual of property, equipment and software, net   $ 2,275